Medlab is an Australian biotechnology company (ASX:MDC) that is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas including pain management, mental health, gut health, diabetes, and allergies.
Patient Josef’s Positive Outlook
Josef recently participated in a Medlab observational study. After the study, Josef’s outlook on life improved along with his ability to complete everyday tasks.
Cannabis Meets Pharma: How Medlab is Taking Cannabinoid Therapies to New Heights
Cannabis remains an emerging space, both in the U.S. and internationally. As prohibition measures have relaxed around the world, though, research has revealed new insights about the therapeutic potential of the plant.